Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Envoy Medical (COCH) Free Cash Flow (2022 - 2025)

Envoy Medical's Free Cash Flow history spans 4 years, with the latest figure at -$5.8 million for Q4 2025.

  • Quarterly results put Free Cash Flow at -$5.8 million for Q4 2025, down 27.45% from a year ago — trailing twelve months through Dec 2025 was -$18.4 million (up 2.9% YoY), and the annual figure for FY2025 was -$18.4 million, up 2.9%.
  • Free Cash Flow for Q4 2025 was -$5.8 million at Envoy Medical, down from -$4.4 million in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of $1.0 million in Q3 2023 to a low of -$11.2 million in Q4 2023.
  • The 4-year median for Free Cash Flow is -$4.2 million (2023), against an average of -$4.0 million.
  • Peak annual rise in Free Cash Flow hit 119.74% in 2023, while the deepest fall reached 910.85% in 2023.
  • Year by year, Free Cash Flow stood at -$2.4 million in 2022, then crashed by 361.4% to -$11.2 million in 2023, then soared by 59.19% to -$4.6 million in 2024, then fell by 27.45% to -$5.8 million in 2025.
  • According to Business Quant data, Free Cash Flow over the past three periods came in at -$5.8 million, -$4.4 million, and -$4.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.